Dr. Zepeda brings over 20 years of drug development experience in the biopharmaceutical arena, with a particular focus in entrepreneurial start-ups. Prior to joining EXUMA Biotechnology, she was an Alliance and Technical Lead for Halozyme Therapeutics including the Roche-Genentech alliance where she was instrumental in leading three US and EU drug approvals for world class biologics. Dr. Zepeda also held positions in leading preclinical candidacy teams for Canji/Schering Plough-Merck in novel gene therapy approaches for cancer and rare disease. Dr. Zepeda earned a B.A. in Physiology from the University of California, San Diego and a Ph.D. in Cellular and Molecular Engineering from the University of Michigan.
Monica Zepeda, Ph.D.VP Alliance & Global Operations